近年来,膜性肾病的发病率逐渐升高,膜性肾病及其并发症受到广泛重视,血栓及栓塞是膜性肾病病程中常见的并发症。膜性肾病患者易处于高凝状态,现代医学对于膜性肾病高凝状态的抗凝治疗及预防性抗凝治疗尚未得到统一标准。中医可基于“阴...近年来,膜性肾病的发病率逐渐升高,膜性肾病及其并发症受到广泛重视,血栓及栓塞是膜性肾病病程中常见的并发症。膜性肾病患者易处于高凝状态,现代医学对于膜性肾病高凝状态的抗凝治疗及预防性抗凝治疗尚未得到统一标准。中医可基于“阴邪”,即瘀血、水湿、痰浊等角度,从本虚标实入手,利用中医内、外治法,辨证论治,个体化治疗膜性肾病高凝状态。In recent years, the incidence of membranous nephropathy has gradually increased, and membranous nephropathy and its complications have been widely valued. Thrombosis and embolism are common complications in the course of membranous nephropathy. Patients with membranous nephropathy are easy to be in a hypercoagulation state, and modern medicine for anticoagulation treatment and preventive anticoagulation treatment has not been unified standard. Chinese medicine can be based on “Yin evil”, that is, blood stasis, water moisture, phlegm turbidity, from the virtual standard and solid, using TCM internal and external treatment, syndrome differentiation, individualized treatment of hypercoagulable state of membranous nephropathy.展开更多
目的:分析健脾益肾汤联合甲泼尼龙琥珀酸钠在慢性肾小球肾炎治疗中的临床效果,并探讨其对肾功能指标的具体影响。方法:选取2022年5月~2023年5月本院的80例慢性肾小球肾炎患者作为研究对象,随机抽取40例患者,设为对照组;另40例患者,设为...目的:分析健脾益肾汤联合甲泼尼龙琥珀酸钠在慢性肾小球肾炎治疗中的临床效果,并探讨其对肾功能指标的具体影响。方法:选取2022年5月~2023年5月本院的80例慢性肾小球肾炎患者作为研究对象,随机抽取40例患者,设为对照组;另40例患者,设为观察组。结果:通过对比分析发现,治疗后观察组患者的肾功能指标明显优于对照组,差异具有统计学意义(P Objective: This study aims to evaluate the clinical efficacy of Jianpi Yishen Decoction combined with methylprednisolone sodium succinate in the treatment of chronic glomerulonephritis and explore its effects on renal function indicators. Methods: A total of 80 patients with chronic glomerulonephritis, treated at our hospital between May 2022 and May 2023, were enrolled in this study. Patients were randomly assigned to either the control group (n = 40) or the observation group (n = 40). Results: Post-treatment analysis indicated that the renal function indicators in the observation group were significantly improved compared to those in the control group, with statistically significant differences (P < 0.05). Conclusion: The combination of Jianpi Yishen Decoction and methylprednisolone sodium succinate offers substantial improvement in renal function indicators for patients with chronic glomerulonephritis, highlighting its promising clinical efficacy.展开更多
文摘近年来,膜性肾病的发病率逐渐升高,膜性肾病及其并发症受到广泛重视,血栓及栓塞是膜性肾病病程中常见的并发症。膜性肾病患者易处于高凝状态,现代医学对于膜性肾病高凝状态的抗凝治疗及预防性抗凝治疗尚未得到统一标准。中医可基于“阴邪”,即瘀血、水湿、痰浊等角度,从本虚标实入手,利用中医内、外治法,辨证论治,个体化治疗膜性肾病高凝状态。In recent years, the incidence of membranous nephropathy has gradually increased, and membranous nephropathy and its complications have been widely valued. Thrombosis and embolism are common complications in the course of membranous nephropathy. Patients with membranous nephropathy are easy to be in a hypercoagulation state, and modern medicine for anticoagulation treatment and preventive anticoagulation treatment has not been unified standard. Chinese medicine can be based on “Yin evil”, that is, blood stasis, water moisture, phlegm turbidity, from the virtual standard and solid, using TCM internal and external treatment, syndrome differentiation, individualized treatment of hypercoagulable state of membranous nephropathy.
文摘目的:分析健脾益肾汤联合甲泼尼龙琥珀酸钠在慢性肾小球肾炎治疗中的临床效果,并探讨其对肾功能指标的具体影响。方法:选取2022年5月~2023年5月本院的80例慢性肾小球肾炎患者作为研究对象,随机抽取40例患者,设为对照组;另40例患者,设为观察组。结果:通过对比分析发现,治疗后观察组患者的肾功能指标明显优于对照组,差异具有统计学意义(P Objective: This study aims to evaluate the clinical efficacy of Jianpi Yishen Decoction combined with methylprednisolone sodium succinate in the treatment of chronic glomerulonephritis and explore its effects on renal function indicators. Methods: A total of 80 patients with chronic glomerulonephritis, treated at our hospital between May 2022 and May 2023, were enrolled in this study. Patients were randomly assigned to either the control group (n = 40) or the observation group (n = 40). Results: Post-treatment analysis indicated that the renal function indicators in the observation group were significantly improved compared to those in the control group, with statistically significant differences (P < 0.05). Conclusion: The combination of Jianpi Yishen Decoction and methylprednisolone sodium succinate offers substantial improvement in renal function indicators for patients with chronic glomerulonephritis, highlighting its promising clinical efficacy.